All In MedTech

Device Trial Radar · NCT00605826

A Randomized, Blinded, Multicenter Study to Evaluate NASHA/Dx for the Treatment of Fecal Incontinence

A Randomized, Subject and Evaluator Blinded, Sham Controlled, Multicenter Study to Evaluate Efficacy and Safety of NASHA/Dx for the Treatment of Fecal Incontinence

Last checked: Nov 20, 2026Latest source record: Aug 18, 2020 (this record)Source: ClinicalTrials.govMethods & limitations

CompletedResults posted on the registryPivotal-lookingRandomized with 206 participants. This is a heuristic, not a regulatory label.

Status

Completed

Enrollment

206

Actual

Start

Sep 7, 2006

Primary completion

Nov 23, 2009

Study completion Nov 23, 2009

Sponsor

Lead sponsor
Bausch Health Americas, Inc.Not on our public-company list
Sponsor type
Industry
Collaborators
Oceana Therapeutics, Inc.; Galderma R&D
First posted
Jan 31, 2008

More device trials from this sponsor

Design

Study type
Interventional
Phase
Not applicable (typical for device studies)
Allocation
Randomized
Model
Parallel
Masking
Double (participant, outcomes assessor)
Primary purpose
Treatment
Who can join
All sexes, from 18 years, up to 75 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

The purpose of this study is to determine the effectiveness and safety of NASHA/Dx when used as an injectable bulking agent in the treatment of fecal incontinence. The study includes a 6-month blinded sham-controlled phase, followed by an open-label phase.

Conditions

  • Fecal Incontinence

Interventions

  • NASHA/Dx (Solesta) GelDevice

    Injection of 4 x 1ml of NASHA/Dx Gel at the start of the blinded phase.

  • Sham InjectionDevice

    Sham injection at the start of the blinded phase.

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Percentage of Participants Who Are Responder50.Time frame: 6 months after last blinded treatment
  2. Percentage of Participants Who Are Responder25.Time frame: 12 months after last treatment

Locations

13 sites in 4 countries. Site status is shown where the registry gives one.

  • University of California, San Francisco, Center for Pelvic Physiology, Dept. of Surgery

    San Francisco, California

  • University of South Florida College of Medicine, Tampa General Hospital

    Tampa, Florida

  • Lahey Clinic, Department of Colon & Rectal Surgery

    Burlington, Massachusetts

10 more study sites with a free account

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.